Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Durdhuradi Taila may help promote hair growth and reduce hair loss.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

The document cannot be understood or processed.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

A gene mutation causes curly hair and hair loss in rats.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

A rare genetic disease causes rickets and often hair loss in young children, which can improve with specific treatments.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

A new group called the Asian Association of Hair Restoration Surgeons (AAHRS) has been created.

Classic PDRN improves wound healing quality by enhancing cell migration.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

A 3-year-old with vitamin D-resistant rickets and severe hair loss died despite treatment, highlighting the need for improved management of the condition.

A special treatment speeds up chronic wound healing by fixing cell energy issues and reversing aging in cells.

The new wound dressing with minoxidil and dexamethasone could speed up healing and reduce scarring in rats.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

A child with skin and heart issues had rare genetic mutations affecting skin and heart cell cohesion.

The microneedle patch boosts hair growth by reducing DHT and oxidative stress.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Dietetic-led cognitive-behavioral therapy may improve treatment for adults with ARFID.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.